AKAN
Akanda Corp.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Akanda Corp.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Largest filed tie
0
filed ties
—
No changes.
No changes.
No thesis.
Annual filing, covered
20-F parsed · Jun 9 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
20-F parsed · Jun 9 '26
Supply-chain ties, covered
None disclosed
Fund holders, covered
No N-PORT holders
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
—
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers; and imports and sells medical cannabis-based products in the United Kingdom. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products in the United Kingdom, Lesotho, and internationally. It intends to supply medicinal-grade cannabis biomass, cannabis flower, and cannabis concentrates to wholesalers; and imports and sells medical cannabis-based products in the United Kingdom. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Expected move
No implied move.
—
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $2,811 | 93.20% | −90.99% |
| Wells Fargo | $178 | 5.90% | new |
| Morgan Stanley | $27 | 0.90% | new |
| Manager | Value | % base | |
|---|---|---|---|
| UBS | $2,811 | 93.20% | −90.99% |
| Wells Fargo | $178 | 5.90% | new |
| Morgan Stanley | $27 | 0.90% | new |
Same SIC code · 6
Same SEC industry code: Definium Therapeutics, Inc., Usana Health Sciences Inc, Niagen Bioscience, Inc. and 3 more; no measured co-movers for Akanda Corp..
Same SIC code · 6
Same SEC industry code: Definium Therapeutics, Inc., Usana Health Sciences Inc, Niagen Bioscience, Inc. and 3 more; no measured co-movers for Akanda Corp..
Akanda Corp.
1.09
+0.05 · +4.70%
post 1.06 −2.65%